Shamir Geller
Shamir Geller/mskcc.org

Shamir Geller: Our experience with JAK inhibitors in patients with cutaneous lymphoma

Shamir Geller, Associate Attending Physician at Memorial Sloan Kettering Cancer Center, shared a post on LinkedIn about a paper he co-authored published in the Journal of Dermatology:

“Just accepted for publication – our experience with JAK inhibitors in patients with cutaneous lymphoma from our Memorial Sloan Kettering Cancer Center cutaneous lymphoma clinic.

More on this topic to come…”

“Oral and Topical Janus Kinase Inhibitors in Patients With Cutaneous T-Cell Lymphoma: A Real-World Single-Center Experience”

Authors: Viviane Liao, Leore Lavin, Michael Ong, Melissa Pulitzer, Alison Moskowitz, Patricia Myskowski, Shamir Geller.

Shamir Geller: Our experience with JAK inhibitors in patients with cutaneous lymphoma